Loading chat...
AL SB59
Bill
Status
5/23/2019
Primary Sponsor
Linda Coleman-Madison
Click for details
AI Summary
SB59 Summary
-
Requires laboratories that test positive or suspected cases of public health importance to submit clinical isolates or additional clinical materials to the Department of Public Health's Bureau of Clinical Laboratories.
-
Expands the definition of "clinical materials" to include patient specimens, nucleic acid, or other laboratory materials when isolates are unavailable, in order of preference.
-
Requires providers of medical services (physicians, hospitals, laboratories, medical facilities) currently rendering or having rendered care to persons with suspected notifiable diseases to provide all records to the State Health Officer or designee upon request.
-
Authorizes the State Board of Health to set reasonable fees for services rendered by the Bureau of Clinical Laboratories, with all collected fees deposited to the State Board of Health for carrying out Chapter 11A of Title 22.
-
Becomes effective on the first day of the third month following passage and approval by the Governor, or upon otherwise becoming law.
Legislative Description
Public health, to require medical labs to submit certain clinical materials to Department of Public Health in certain cases of certain diseases, testing of personnel, State Board of Health authorized to set reasonable schedule of fees for services rendered under Chapter 11A of Title 22, Sec. 22-11A-42 added; Secs. 22-11A-4, 22-11A-40 am'd.
Public Health Department
Last Action
Assigned Act No. 2019-302.
5/23/2019